Amphastar Pharmaceuticals, Inc. Financial Ratios — AMPH

Profitability (USD)

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Return on Common Equity (%)	- -	58.41	17.47	-15.63	-4.52	14.97	5.08	-8.19	53.23	1.2	41.67	40.43	40.39	32.62	15.88
Return on Assets (%)	- -	11.4	3.62	-2.94	-0.72	2.4	0.83	-1.19	8.89	0.23	9.54	12.93	12.2	10.32	6.12
Return on Capital (%)	- -	37.3	12.16	- -	- -	10.01	- -	- -	27.17	0.78	23.85	28.17	22.69	16.44	9.31
Return on Invested Capital (%)	- -	14.01	4.32	- -	- -	2.89	- -	- -	-0.01	0.51	9.83	14.41	16.93	13.07	7.87
Gross Margin (%)	23.75	44.2	37.86	24.35	30.75	40.83	37.68	36.31	40.92	40.97	45.63	49.87	54.49	51.08	49.46
EBITDA Margin (%)	-18.87	19.08	13.36	-1.68	2.53	11.78	4.95	2.68	6.54	10.33	22.03	27.21	37.05	35.88	28.28
Operating Margin (%)	-28.29	13.45	7.67	-8.54	-2.74	6.03	-1.63	-2.93	-0.01	3.13	15.96	21.54	30.57	28.06	19.5
Incremental Operating Margin (%)	- -	70.92	-38.94	- -	- -	610.92	- -	- -	- -	39.99	67.03	61.44	61.54	9.63	538.21
Pretax Margin (%)	-26.94	12.67	7.5	-8.62	-4.12	5.73	0.52	-3.37	18.68	1.33	19.22	23.26	26.59	25.93	17.17
Profit Margin (%)	6.55	8.86	5.16	-5.08	-1.11	3.85	1.52	-1.95	15.18	0.4	14.19	18.31	21.34	21.79	13.63
Net Income to Common Margin (%)	6.55	8.86	5.16	-5.08	-1.11	3.85	1.52	-1.95	15.18	0.4	14.19	18.31	21.34	21.79	13.63
Effective Tax Rate (%)	- -	30.08	31.14	- -	- -	32.88	- -	- -	22.79	76.34	24.52	20.23	18.58	15.64	20.65
Dvd Payout Ratio (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	58.41	17.47	-15.63	-4.52	14.97	5.08	-8.19	53.23	1.2	41.67	40.43	40.39	32.62	15.88

Credit (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Total Debt	- -	38	32	44	41	38	47	50	67	67	105	103	624	651	656
ST Debt	- -	22	22	8	11	5	6	18	11	16	5	6	4	7	10
LT Debt	- -	16	10	36	30	32	41	32	56	52	99	97	619	644	646
Total Debt/EBITDA	- -	0.97	1.05	-12.36	6.47	1.26	3.96	6.36	3.16	1.86	1.09	0.76	2.61	2.48	3.22
Net Debt/EBITDA	- -	-0.31	-0.7	6.83	-3.93	-1.15	-1.55	-4.58	-1.26	-1.28	-0.51	-0.59	1.87	1.71	2.16
Total Debt/EBIT	- -	1.38	1.83	-2.43	-5.96	2.45	-12.05	-5.82	-1,708.33	6.14	1.5	0.95	3.17	3.17	4.67
Net Debt/EBIT	- -	-0.44	-1.22	1.34	3.62	-2.25	4.71	4.19	680.77	-4.22	-0.71	-0.75	2.26	2.19	3.14
EBITDA to Interest Expense	-38.23	49.73	32.04	-5.8	6.44	29.35	14.4	32.48	177.16	96.61	108.95	73.55	8.79	8.66	7.99
EBITDA-CapEx/Interest Expense	-55.31	18.3	13.62	-39.46	-9.77	8.47	-28.09	-160.14	-172.04	6.09	77.93	60.53	7.39	7.3	6.53
EBIT to Interest Expense	-57.33	35.07	18.39	-29.53	-6.99	15.02	-4.74	-35.49	-0.33	29.29	78.97	58.23	7.25	6.77	5.51
Interest Expense	1	1	1	1	1	1	1	- -	- -	- -	1	2	27	30	25
Common Equity/Total Assets	- -	19.51	21.79	16.21	15.46	16.57	16.11	13.14	19.83	18.66	26.86	36.62	27.05	36.06	40.93
Long-Term Debt/Equity (%)	- -	6.83	4	12.81	10.21	9.83	12.24	8.78	13.03	11.51	22.33	18.26	96.85	87.88	81.95
Long-Term Debt/Capital (%)	- -	15.96	9.5	33.8	29.74	29.8	34.09	21.38	24.31	22.31	34.9	25.79	59.96	52.78	48.87
Long-Term Debt/Total Assets (%)	- -	5.02	2.97	9.27	7.73	7.56	9.05	6.23	9.49	8.18	14.81	13.01	40.93	40.79	39.68
Total Debt/Equity (%)	- -	16.28	12.79	15.5	13.91	11.46	14.13	13.78	15.58	14.99	23.49	19.4	97.53	88.84	83.16
Total Debt/Capital (%)	- -	38.02	30.36	40.91	40.52	34.74	39.36	33.56	29.07	29.06	36.72	27.41	60.38	53.35	49.59
Total Debt/Total Assets (%)	- -	11.97	9.5	11.22	10.53	8.82	10.45	9.78	11.35	10.66	15.59	13.83	41.22	41.24	40.26
Net Debt to Equity	- -	-5.23	-8.51	-8.56	-8.45	-10.52	-5.52	-9.91	-6.21	-10.29	-11.08	-15.17	69.71	61.49	55.81
Net Debt/Capital (%)	- -	-24.55	-40.87	-61.89	-70.64	-95.59	-34.01	-57.08	-17.08	-33.27	-31.12	-36.76	50.16	42.17	38.19
EBITDA	-22	39	31	-4	6	30	12	8	21	36	96	136	239	263	204
EBITDA-CapEx	-32	14	13	-24	-10	9	-23	-39	-20	2	69	112	201	222	166
Operating Income (Loss)	-33	27	18	-18	-7	15	-4	-9	- -	11	70	107	197	205	140

Liquidity (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Cash Ratio	- -	0.84	0.82	1.08	1.1	1.2	1.02	0.83	0.95	0.94	1.32	1.85	1.14	1.28	1.79
Current Ratio	- -	2.76	2.64	3.16	2.93	3.04	2.79	2.06	2.84	2.49	3.06	3.99	2.17	3.07	4.02
Quick Ratio	- -	1.47	1.23	1.45	1.66	1.64	1.64	1.32	1.46	1.53	2.08	2.79	1.65	2.07	2.8
CFO/Avg Current Liab	- -	-0.05	0.49	0.33	0.17	0.64	0.61	0.44	0.42	0.57	0.91	0.9	1.15	1.07	0.94
Common Equity/Total Assets	- -	19.51	21.79	16.21	15.46	16.57	16.11	13.14	19.83	18.66	26.86	36.62	27.05	36.06	40.93
Long-Term Debt/Equity (%)	- -	6.83	4	12.81	10.21	9.83	12.24	8.78	13.03	11.51	22.33	18.26	96.85	87.88	81.95
Long-Term Debt/Capital (%)	- -	15.96	9.5	33.8	29.74	29.8	34.09	21.38	24.31	22.31	34.9	25.79	59.96	52.78	48.87
Long-Term Debt/Total Assets (%)	- -	5.02	2.97	9.27	7.73	7.56	9.05	6.23	9.49	8.18	14.81	13.01	40.93	40.79	39.68
Total Debt/Equity (%)	- -	16.28	12.79	15.5	13.91	11.46	14.13	13.78	15.58	14.99	23.49	19.4	97.53	88.84	83.16
Total Debt/Capital (%)	- -	38.02	30.36	40.91	40.52	34.74	39.36	33.56	29.07	29.06	36.72	27.41	60.38	53.35	49.59
Total Debt/Total Assets (%)	- -	11.97	9.5	11.22	10.53	8.82	10.45	9.78	11.35	10.66	15.59	13.83	41.22	41.24	40.26
CFO/Total Liabilities	- -	-1.96	35.6	19.58	11.29	39.15	33.42	25.6	26.19	31.38	43.36	41.8	21.01	25.25	18.57
CFO/CapEx	1.92	-0.07	1.76	1.03	0.67	1.8	1.12	0.82	1	1.69	3.57	3.71	4.81	5.2	4.2
Altman's Z-Score	- -	1.85	1.74	3.88	5.35	6.56	5.7	4.77	4.66	4.38	4.82	6.06	4.48	3.95	3.42

Working Capital (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Accounts Receivable Turnover	- -	11.22	7.53	8.87	8.97	8.5	7.65	6.68	6.61	6.28	6.05	5.95	6.33	5.83	5.14
Days Sales Outstanding	- -	32.52	48.46	41.13	40.69	42.92	47.7	54.6	55.22	58.1	60.37	61.3	57.7	62.64	70.95
Inventory Turnover	- -	4.44	2.35	2.09	2.28	2.01	2.09	2.82	2.12	1.99	2.51	2.55	2.8	2.76	2.2
Days Inventory Outstanding	- -	82.24	155.1	174.53	160.31	181.84	174.81	129.26	172.33	183.23	145.4	143.29	130.32	132.28	165.85
Accounts Payable Turnover	- -	18.73	8.48	11.24	13.52	9.47	7.3	8.07	8.22	7.8	10.05	12.22	12.87	14.51	12.26
Accounts Payable Turnover Days	- -	19.49	43.05	32.48	26.99	38.54	49.97	45.25	44.43	46.77	36.32	29.88	28.37	25.15	29.76
Cash Conversion Cycle	- -	95.27	160.51	183.18	174.02	186.21	172.54	138.61	183.12	194.56	169.45	174.71	159.65	169.77	207.03
Inventory to Cash Days	- -	-49.72	-106.63	-133.39	-119.62	-138.91	-127.12	-74.66	-117.11	-125.13	-85.03	-81.99	-72.61	-69.64	-94.9
Inventories	- -	51	70	82	71	80	64	69	111	97	93	104	106	154	177
Raw Materials	- -	29	34	42	30	36	20	30	59	47	42	48	50	82	107
Work In Process	- -	9	15	16	26	22	22	30	36	37	33	37	31	33	40
Finished Goods	- -	19	27	25	15	21	21	9	16	13	18	19	25	39	30
Other Inventory	- -	- -	- -	- -	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Market Capitalization	- -	- -	- -	487	640	836	887	923	906	946	1,113	1,360	2,985	1,798	1,252
- Cash & Cash Equivalents	- -	50	54	68	66	72	66	86	74	93	126	156	144	152	170
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	32	46	46	- -	- -	- -	- -	- -
+ Total Debt	- -	38	32	44	41	38	47	50	67	67	105	103	624	651	656
Enterprise Value	- -	-12	-21	463	615	801	866	916	934	954	1,081	1,287	3,352	2,227	1,625
Total Capital	- -	100	106	107	101	109	120	150	229	231	285	374	1,033	1,219	1,323
Total Debt/Capital (%)	- -	38.02	30.36	40.91	40.52	34.74	39.36	33.56	29.07	29.06	36.72	27.41	60.38	53.35	49.59
Total Debt / EV	- -	-3.11	-1.5	0.09	0.07	0.05	0.05	0.05	0.07	0.07	0.1	0.08	0.19	0.29	0.4
EV/Sales	- -	- -	- -	2.2	2.44	3.14	3.61	3.11	2.9	2.73	2.47	2.58	5.2	3.04	2.26
EV/EBITDA	- -	- -	- -	- -	96.76	26.64	72.79	116.08	44.29	26.4	11.21	9.48	14.04	8.48	7.98
EV/EBIT	- -	- -	- -	- -	- -	52.07	- -	- -	- -	87.09	15.46	11.97	17.02	10.84	11.57
EV/Cash Flow to Firm	- -	- -	- -	21.62	56.17	20.4	20.81	23.89	22.31	16.63	10.95	14.2	16.3	9.32	9.22
EV/Free Cash Flow to Firm	- -	- -	- -	11.05	22.82	13.21	11.29	10.76	11.19	10.46	8.57	11.22	13.75	7.95	7.61
Diluted Market Cap	- -	- -	- -	487	640	875	931	923	963	988	1,159	1,469	3,278	1,933	1,291
Diluted Enterprise Value	- -	-12	-21	463	615	840	912	919	1,002	1,009	1,138	1,415	3,757	2,432	1,777
EV per Share	- -	- -	- -	11.03	13.67	17.65	18.78	19.75	19.87	20.28	22.62	26.51	69.45	45.99	34.76
TTM Sales	118	204	230	210	252	255	240	295	322	350	438	499	644	732	720
TTM EBITDA	-22	39	31	-4	6	30	12	8	21	36	96	136	239	263	204
TTM Operating Income	-33	27	18	-18	-7	15	-4	-9	- -	11	70	107	197	205	140
TTM Cash Flow to Firm	19	-1	32	21	11	39	42	38	42	57	99	91	206	239	176
TTM Free Cash Flow to Firm	29	24	49	42	27	61	77	85	83	91	126	115	244	280	213

Multiples (USD)

API ChatGPT

	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y	2023 Y	2024 Y	2025 Y
As of date	12/31/2011	12/31/2012	12/31/2013	12/31/2014	12/31/2015	12/31/2016	12/31/2017	12/31/2018	12/31/2019	12/31/2020	12/31/2021	12/31/2022	12/31/2023	12/31/2024	12/31/2025

Price/Free Cash Flow	- -	- -	- -	11.72	23.98	14.6	12.52	10.86	11.55	10.84	9.24	12.98	14.79	7.6	6.68
EV/EBIT	- -	- -	- -	- -	- -	52.07	- -	- -	- -	87.09	15.46	11.97	17.02	10.84	11.57
Enterprise Value	- -	-12	-21	463	615	801	866	916	934	954	1,081	1,287	3,352	2,227	1,625
Low Price	- -	- -	- -	6.67	10.57	10.5	12.05	14.4	16.71	12.32	16.91	22.07	27.58	36.48	20.39
EV/Sales	- -	- -	- -	2.2	2.44	3.14	3.61	3.11	2.9	2.73	2.47	2.58	5.2	3.04	2.26
EV/EBITDA	- -	- -	- -	- -	96.76	26.64	72.79	116.08	44.29	26.4	11.21	9.48	14.04	8.48	7.98
Price/Earnings	- -	- -	- -	- -	- -	85.11	243.24	- -	18.52	674.22	17.91	14.89	21.7	11.27	12.76
Price/Earnings Average	- -	- -	- -	-41.68	-230.62	73.52	210.88	-149.14	19.98	631.65	14.91	16.7	16.18	13.85	12.88
Price/Earnings High	- -	- -	- -	-49.11	-295.22	100.5	252.22	-183.87	24.41	760.72	18.34	23.62	23.74	20.01	18.59
Price/Earnings Low	- -	- -	- -	-26.16	-170.52	48.52	152.34	-116.43	16.04	413.22	13.01	11.73	9.68	11.08	9.72
Price/Book Value	- -	- -	- -	7.72	10.61	11.8	12.21	13.68	7.79	8.03	6.17	5.01	7.29	3.16	1.88
Price/Book Value Average	- -	- -	- -	7.07	10.65	10.19	10.59	12.68	8.4	7.52	5.13	5.62	5.44	3.88	1.89
Price/Book Value High	- -	- -	- -	8.32	13.64	13.93	12.66	15.63	10.27	9.06	6.32	7.94	7.98	5.61	2.73
Price/Book Value Low	- -	- -	- -	4.43	7.88	6.72	7.65	9.9	6.75	4.92	4.48	3.94	3.25	3.11	1.43
Price/Tangible Book Value	- -	- -	- -	2.04	2.5	3	3.07	2.87	2.35	2.32	2.74	2.77	114.26	12.7	5.62
Price/Tangible Book Value Average	- -	- -	- -	1.86	2.51	2.59	2.66	2.66	2.53	2.17	2.28	3.11	85.18	15.6	5.67
Price/Tangible Book Value High	- -	- -	- -	2.2	3.22	3.54	3.19	3.28	3.09	2.62	2.8	4.39	124.99	22.54	8.18
Price/Tangible Book Value Low	- -	- -	- -	1.17	1.86	1.71	1.93	2.07	2.03	1.42	1.99	2.18	50.95	12.47	4.28
Price/Sales	- -	- -	- -	2.31	2.54	3.28	3.69	3.13	2.81	2.7	2.54	2.73	4.63	2.46	1.74
Price/Sales Average	- -	- -	- -	2.12	2.56	2.83	3.2	2.9	3.03	2.53	2.11	3.06	3.45	3.02	1.75
Price/Sales High	- -	- -	- -	2.5	3.27	3.87	3.83	3.58	3.71	3.05	2.6	4.33	5.07	4.36	2.53
Price/Sales Low	- -	- -	- -	1.33	1.89	1.87	2.31	2.27	2.44	1.66	1.85	2.15	2.07	2.41	1.32
Price/Cash Flow	- -	- -	- -	23.14	59.9	21.68	22.62	24.17	21.7	16.52	11.36	15.25	16.27	8.43	8.02
Price/Cash Flow Average	- -	- -	- -	21.18	60.18	18.72	19.61	22.41	23.41	15.48	9.45	17.11	12.13	10.35	8.09
Price/Cash Flow High	- -	- -	- -	24.96	77.03	25.59	23.46	27.62	28.61	18.64	11.63	24.2	17.8	14.96	11.68
Price/Cash Flow Low	- -	- -	- -	13.29	44.49	12.36	14.17	17.49	18.8	10.12	8.24	12.02	7.25	8.28	6.11
Price/Free Cash Flow Average	- -	- -	- -	10.73	24.09	12.61	10.86	10.07	12.47	10.16	7.69	14.56	11.02	9.33	6.74
Price/Free Cash Flow High	- -	- -	- -	12.64	30.84	17.24	12.99	12.41	15.23	12.23	9.46	20.59	16.18	13.49	9.73
Price/Free Cash Flow Low	- -	- -	- -	6.74	17.81	8.32	7.84	7.86	10.01	6.64	6.71	10.22	6.59	7.46	5.09
EV/Sales Average	- -	- -	- -	2	2.46	2.69	3.13	2.89	3.15	2.59	2.07	2.95	4.2	3.7	2.43
EV/Sales High	- -	- -	- -	2.38	3.17	3.73	3.75	3.57	3.83	3.11	2.55	4.22	5.81	5.04	3.21
EV/Sales Low	- -	- -	- -	1.22	1.79	1.73	2.24	2.25	2.56	1.72	1.8	2.04	2.81	3.1	2
EV/EBITDA Average	- -	-0.31	-0.7	-119.32	97.23	22.87	63.09	107.89	48.23	25.11	9.38	10.85	11.33	10.31	8.59
EV/EBITDA High	- -	-0.31	-0.7	-141.8	125.56	31.69	75.76	133.13	58.53	30.12	11.59	15.5	15.68	14.06	11.34
EV/EBITDA Low	- -	-0.31	-0.7	-72.34	70.86	14.7	45.15	84.11	39.09	16.63	8.15	7.5	7.58	8.63	7.07
EV/EBIT Average	- -	-0.44	-1.22	-23.46	-89.56	44.7	-191.88	-98.76	-26,072.42	82.82	12.94	13.7	13.73	13.18	12.46
EV/EBIT High	- -	-0.44	-1.22	-27.87	-115.66	61.93	-230.42	-121.86	-31,637.29	99.36	15.99	19.58	19.01	17.97	16.45
EV/EBIT Low	- -	-0.44	-1.22	-14.22	-65.27	28.73	-137.31	-76.99	-21,132.6	54.85	11.25	9.47	9.19	11.03	10.25
Last Price	- -	- -	- -	11.61	14.23	18.42	19.24	19.9	19.29	20.11	23.29	28.02	61.85	37.13	26.78
High Price	- -	- -	- -	12.52	18.3	21.75	19.95	22.74	25.43	22.69	23.85	44.46	67.66	65.92	39.01
Enterprise Value Average	- -	-12	-21	422	618	687	751	852	1,017	907	904	1,473	2,705	2,708	1,749
Enterprise Value High	- -	-12	-21	501	798	952	901	1,051	1,234	1,088	1,118	2,105	3,745	3,691	2,309
Enterprise Value Low	- -	-12	-21	256	450	442	537	664	824	601	786	1,018	1,810	2,266	1,439

Shares Outstanding	- -	43	45	45	45	46	47	47	47	47	48	48	48	48	46
Diluted Weighted Avg Shares	8	8	8	42	45	48	48	46	50	49	50	52	53	52	48
Basic Weighted Avg Shares	8	8	8	42	45	45	46	46	47	47	48	49	48	48	47
Revenue per Share	14.79	25.54	28.71	5.02	5.59	5.62	5.21	6.35	6.86	7.44	9.16	10.28	13.35	15.11	15.4
EBITDA per Share	-2.79	4.87	3.84	-0.08	0.14	0.66	0.26	0.17	0.45	0.77	2.02	2.8	4.95	5.42	4.36
Operating Income per Share	-4.18	3.44	2.2	-0.43	-0.15	0.34	-0.08	-0.19	- -	0.23	1.46	2.21	4.08	4.24	3
Basic EPS, GAAP	0.97	2.26	1.48	-0.25	-0.06	0.22	0.08	-0.12	1.04	0.03	1.3	1.88	2.85	3.29	2.1
Basic EPS from Cont Ops	0.97	2.26	1.48	-0.25	-0.06	0.22	0.08	-0.14	0.99	0.02	1.32	1.88	2.85	3.29	2.1
Diluted EPS, GAAP	0.97	2.26	1.48	-0.25	-0.06	0.21	0.08	-0.12	0.98	0.03	1.25	1.74	2.6	3.06	2.03
Diluted EPS from Cont Ops	0.97	2.26	1.48	-0.25	-0.06	0.21	0.08	-0.14	0.93	0.02	1.27	1.74	2.6	3.06	2.03
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	2.39	-0.21	3.88	0.5	0.24	0.85	0.85	0.82	0.89	1.22	2.05	1.84	3.8	4.41	3.34
Free Cash Flow per Basic Share	1.14	-3.29	1.68	0.01	-0.12	0.38	0.09	-0.19	- -	0.5	1.48	1.34	3.01	3.56	2.55
Cash & Equivalents per Share	- -	6.28	6.7	1.62	1.47	1.61	1.48	1.92	1.82	2.25	2.86	3.62	5.32	4.58	6.05
Book Value per Share	- -	7.74	9.23	1.5	1.34	1.56	1.58	1.45	2.48	2.5	3.77	5.6	8.48	11.74	14.27
Tangible Book Value per Share	- -	23.89	26.42	5.7	5.69	6.15	6.26	6.94	8.22	8.68	8.51	10.12	0.54	2.92	4.77

Amphastar Pharmaceuticals, Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)